Literature DB >> 18295153

Is there a need to reformulate attention deficit hyperactivity disorder criteria in future nosologic classifications?

Luis Augusto Rohde1.   

Abstract

The development of classification systems in psychiatry has been a complex task. In clinical settings, these classification systems help communication about disorders among professionals and between them and their patients. In addition, a diagnosis based on these nosologic systems has a central role for mental health insurance policies. There is a recent interest in research opportunities for improving the nosology of attention deficit hyperactivity disorder (ADHD) in future classification systems like the DSM-V and the ICD-11. This article addresses the potential need to reformulate ADHD criteria in future nosologic classifications.

Entities:  

Mesh:

Year:  2008        PMID: 18295153     DOI: 10.1016/j.chc.2007.11.007

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN: 1056-4993


  11 in total

1.  Attention-deficit/hyperactivity disorder in perspective.

Authors:  Luis Augusto Rohde
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-10       Impact factor: 4.785

2.  ADHD in a representative sample of the Brazilian population: estimated prevalence and comparative adequacy of criteria between adolescents and adults according to the item response theory.

Authors:  Guilherme Polanczyk; Ronaldo Laranjeira; Marcos Zaleski; Ilana Pinsky; Raul Caetano; Luis Augusto Rohde
Journal:  Int J Methods Psychiatr Res       Date:  2010-09       Impact factor: 4.035

3.  Cathechol-O-methyltransferase Val(158)Met polymorphism is associated with disruptive behavior disorders among children and adolescents with ADHD.

Authors:  Angélica Salatino-Oliveira; Julia P Genro; Ana P Guimarães; Rodrigo Chazan; Cristian Zeni; Marcelo Schmitz; Guilherme Polanczyk; Tatiana Roman; Luis A Rohde; Mara H Hutz
Journal:  J Neural Transm (Vienna)       Date:  2012-01-21       Impact factor: 3.575

4.  Developmental differences in structure of attention-deficit/hyperactivity disorder (ADHD) between childhood and adulthood.

Authors:  Michelle M Martel; Alexander von Eye; Joel Nigg
Journal:  Int J Behav Dev       Date:  2012-07

Review 5.  DSM-V and the future diagnosis of attention-deficit/hyperactivity disorder.

Authors:  James M Swanson; Timothy Wigal; Kimberley Lakes
Journal:  Curr Psychiatry Rep       Date:  2009-10       Impact factor: 5.285

6.  Prevalence of psychiatric disorders in a Brazilian birth cohort of 11-year-olds.

Authors:  Luciana Anselmi; Bacy Fleitlich-Bilyk; Ana Maria B Menezes; Cora L Araújo; Luis A Rohde
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-04-18       Impact factor: 4.328

7.  Attention deficit hyperactivity disorder: a Rasch analysis of the SWAN Rating Scale.

Authors:  Deidra J Young; Florence Levy; Neilson C Martin; David A Hay
Journal:  Child Psychiatry Hum Dev       Date:  2009-05-20

8.  Differentiating attention-deficit/hyperactivity disorder inattentive and combined types: a (1)H-magnetic resonance spectroscopy study of fronto-striato-thalamic regions.

Authors:  Pedro E M S Ferreira; André Palmini; Claiton H D Bau; Eugenio Horacio Grevet; João Rubião Hoefel; Luis Augusto Rohde; Maurício Anés; Eloisa Elena Ferreira; Paulo Belmonte-de-Abreu
Journal:  J Neural Transm (Vienna)       Date:  2009-04-28       Impact factor: 3.575

9.  Response to methylphenidate in children and adolescents with ADHD: does comorbid anxiety disorders matters?

Authors:  Sheila P Garcia; Julia Guimarães; Juliana F Zampieri; Ana Luiza Martinez; Guilherme Polanczyk; Luis Augusto Rohde
Journal:  J Neural Transm (Vienna)       Date:  2009-04-16       Impact factor: 3.575

10.  Full syndrome and subthreshold attention-deficit/hyperactivity disorder in a Korean community sample: comorbidity and temperament findings.

Authors:  Soo-Churl Cho; Boong-Nyun Kim; Jae-Won Kim; Luis Augusto Rohde; Jun-Won Hwang; Dong-Seon Chungh; Min-Sup Shin; In Kyoon Lyoo; Bock-Ja Go; Sang-Eun Lee; Hyo-Won Kim
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-02-05       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.